 |
Fauci Presents New Data On Structured Intermittent Therapy For HIV
Dr. Anthony S. Fauci presented new
data on structured intermittent therapy at the XIII World AIDS Conference. According to Fauci's presentation, for some HIV-infected patients whose plasma levels of virus have fallen to undetectable levels while on HAART, it may prove feasible to move from a continuous HAART regimen to intermittent therapy. More...
|
|
 |
Important Revisions To Safety Labeling For Relenza®
Glaxo Wellcome Inc. is writing to health professionals in order to inform them of important revisions to the safety labeling for Relenza (zanamivir for inhalation), which is approved for the treatment of uncomplicated acute illness due to influenza virus.
More...
|
|
 |
The Gates Foundation, Merck And The Government Of Botswana Launch New HIV Initiative
The Bill &
Melinda Gates Foundation, Merck & Co., Inc. and the Republic of
Botswana today announced the establishment of the "Botswana Comprehensive
HIV/AIDS Partnership", a new initiative to improve the overall state of
HIV/AIDS care and treatment in Botswana. The collaboration will endeavor to advance HIV/AIDS prevention in Botswana, a country where nearly one-third of the adult population is HIV-positive. More...
|
|
 |
OraQuick® Rapid HIV Test Demonstrated To Global AIDS/HIV Policy Leaders
A new oral fluid test called OraQuick® HIV-1/2 rapid HIV
test was demonstrated to global AIDS/HIV policy leaders and decision makers attending the XIII International AIDS Conference currently underway in Durban,
South Africa. OraQuick® is a portable, non-invasive oral fluid test for HIV 1 and 2 antibodies, which provides highly accurate results in about 20
minutes. More... |
|